ClinicalTrials.gg
Enrolling by invitationNCT07465770Updated Mar 12, 2026

Optimizing Medical Decisions and Care for Adult Orphans

An interventional study of Caring for Adult Orphans in Social Isolation and Health Services Accessibility, sponsored by Chang Gung University. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Chang Gung University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to evaluate the effectiveness of a training program designed to improve clinicians' ability to care for adult orphans. A randomized controlled trial will be conducted to examine the effects of the training program on clinicians' knowledge, self-efficacy, and clinical practice related to caring for adult orphans at baseline, 1 month, and 3 months after the intervention.

Read the detailed description

A training program for clinicians on caring for adult orphans has been developed based on an extensive review of the literature. This study will evaluate the effectiveness of the program in clinical settings.

A randomized controlled trial will be conducted among clinicians working in healthcare settings. Participants will be randomly assigned to either an intervention group receiving the training program or a control group receiving usual practice. The effectiveness of the training program will be assessed by measuring clinicians' knowledge, self-efficacy, and clinical practice related to caring for adult orphans using structured questionnaires at baseline, 1 month after the intervention, and 3 months after the intervention.

02

Conditions studied

  • Social Isolation
  • Health Services Accessibility

Browse trials for

Keywords

  • clinicians
  • knowledge
  • self-efficacy
  • clinical practice
  • adult orphans
03

In context

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's planned enrollment of 100 is above the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Lead sponsor

Chang Gung University is the lead sponsor of 66 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full-time healthcare professionals working in the selected outpatient or inpatient divisions.
  • Includes physicians, nurses, social workers, and psychologists.
  • Willing and able to provide for participation.

Exclusion criteria

Exclusion Criteria:

-There are no specific exclusion criteria. All healthcare professionals meeting the inclusion criteria are eligible.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Participants receiving Caring for Adult Orphans

    Behavioral: Caring for Adult Orphans

  • No intervention
    Control group

Interventions

  • BehavioralCaring for Adult Orphans

    The Caring for Adult Orphans training program has been developed to improve clinicians' knowledge, self-efficacy, and clinical practice in caring for adult orphans. The program consists of three components: A film highlighting issues related to adult orphans and unbefriended older adults. A second film introducing the Hospice Palliative Care Act and the Patient Right to Autonomy Act to enhance participants' understanding of relevant legal and ethical frameworks. Three common clinical scenarios involving the care of adult orphans, used for group discussion and structured debriefing.

06

What researchers measure

Primary outcomes

  1. Clinicians' Knowledge about Caring for Adult Orphans

    Knowledge regarding the care of adult orphans measured using the Clinicians' Knowledge about Caring for Adult Orphans Scale, a 17-item questionnaire developed by the research team. Each correct response is scored as 1 point and incorrect or "do not know" responses are scored as 0 points. Total scores range from 0 to 17, with higher scores indicating greater knowledge. Unit of Measure: Score on knowledge scale (0-17)

    Time frame: Baseline, 1 month, and 3 months after the intervention

  2. Clinicians' Self-Efficacy about Caring for Adult Orphans

    Self-efficacy in caring for adult orphans measured using the Clinicians' Self-Efficacy about Caring for Adult Orphans Scale, a 10-item questionnaire rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 10 to 50, with higher scores indicating greater self-efficacy. Unit of Measure: Score on self-efficacy scale (10-50)

    Time frame: Baseline, 1 month, and 3 months after the intervention

  3. Clinicians' Clinical Practice about Caring for Adult Orphans

    Clinical practice in caring for adult orphans measured using the Clinicians' Clinical Practice about Caring for Adult Orphans Scale, a 10-item questionnaire rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree). Total scores range from 10 to 50, with higher scores indicating better clinical practice. Unit of Measure: Score on clinical practice scale (10-50)

    Time frame: Baseline, 1 month, and 3 months after the intervention

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The informed consent obtained from participants did not include provisions for sharing individual participant data with external researchers; therefore, IPD will not be made available.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Oct 2026, 9 months after the start.

Of 155 non-industry interventional studies with no phase under Social Isolation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's planned 9 months is below that.

Counting every sponsor, half of 156 studies reached it within 18 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2026
First posted
Mar 12, 2026
StartActual
Jan 30, 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Jan 31, 2027
Last update
Mar 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07465770
Lead sponsor
Chang Gung University
Collaborators
National Science and Technology Council, Taiwan
Responsible party
Yun-Fang Tsai (Professor, Chang Gung University) — Principal investigator
First posted
Mar 12, 2026
Start date
Jan 30, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Mar 12, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion